Unknown

Dataset Information

0

ARRIVE guidelines checklist

ABSTRACT: The ARRIVE guidelines detailing the methodology and the outcome of the study

ORGANISM(S): Mus musculus (mouse)

SUBMITTER:  

PROVIDER: S-BSST792 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4)
2017-01-20 | LDS-1370 | LINCS
Unknown FoxO3a nuclear-cytoplasmic pulsing dynamics in a mammary epithelial cell line following growth-factor treatment with varying ERK/AKT activation loads. Dataset 2 of 3: single-cell reporter pulsing metrics.
2017-05-02 | LDS-1383 | LINCS
Unknown Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2)
2017-01-20 | LDS-1366 | LINCS
Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 8 of 9: Calculated dose-response metrics for biological replicate 2
2017-03-14 | LDS-1380 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3.
2017-03-14 | LDS-1228 | LINCS
Unknown MEMA PC3 Staining Set 2 no H3
2016-03-09 | LDS-1319 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3.
2017-03-14 | LDS-1231 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values.
2016-04-01 | LDS-1294 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3.
2017-03-14 | LDS-1255 | LINCS
Unknown MGH (CMT) Growth Inhibition Assay Protocol (9 compound doses: 8 nM to 0.03125 nM) -- DNA Staining
2014-05-30 | EDS-1008 | LINCS